rethinkPeptides Search
Menu
Study breakdown

How Sleeve Gastrectomy Changes Gut Hormones Like Ghrelin and GLP-1 to Reduce Hunger

evidence
The takeaway

Sleeve gastrectomy dramatically altered gut peptide hormone levels — lowering the hunger hormone ghrelin while boosting satiety hormones GLP-1 and cholecystokinin — explaining how the surgery reduces appetite.

Lowest ghrelin + highest GLP-1

Sleeve gastrectomy patients showed the most favorable gut peptide hormone profile of all three groups, explaining their reduced hunger and improved satiation

What the researchers found

Sleeve gastrectomy patients showed significantly different gut peptide hormone profiles compared to both morbidly obese and non-obese groups:

- Lowest ghrelin concentrations (the primary hunger-stimulating peptide)

- Higher early postprandial cholecystokinin (CCK) peaks — a satiety peptide

- Higher early postprandial glucagon-like peptide 1 (GLP-1) peaks — a satiety and insulin-stimulating peptide

- Accelerated gastric emptying compared to both control groups

- Improved insulin resistance pattern compared to morbidly obese patients

- Reduced hunger and increased satiation scores

Interestingly, no differences in hunger and satiation were observed between morbidly obese and non-obese groups before surgery, suggesting the hormonal changes after surgery drive the appetite effects rather than stomach size alone.

Why it matters

This study demonstrates that sleeve gastrectomy works not just by making the stomach smaller, but by fundamentally rewiring the gut's peptide hormone signaling. Understanding these hormonal mechanisms helps explain why bariatric surgery is so much more effective than dieting alone — and connects to why GLP-1 drugs like semaglutide mimic some of these same effects pharmacologically.

How the study worked

Case-control study (registered trial NCT02414893) comparing three groups: morbidly obese (n=16), post-sleeve gastrectomy (n=8), and non-obese controls (n=16). After a 10-hour fast, participants consumed a standardized 200 mL liquid meal (400 kcal + 1.5 g paracetamol for gastric emptying measurement). Hunger, satiation, hormone concentrations, and gastric and gallbladder emptying were measured at multiple time points over 4 hours.

What this study cannot tell us

The sleeve gastrectomy group was small (n=8). The study was cross-sectional, not longitudinal, so pre-surgery baseline data from the same patients was not available. Long-term hormonal changes were not assessed. A single liquid meal may not represent the full range of dietary responses. The exact timing of surgery relative to testing was not specified in the abstract.

How to read the evidence

This is a registered clinical trial (NCT02414893) with a case-control design. While the methodology is sound and includes detailed hormonal profiling, the small sample size (particularly n=8 for the surgery group) limits statistical power.

When this study was published

Published in 2015 in the American Journal of Clinical Nutrition, this study provided early mechanistic evidence connecting bariatric surgery to gut peptide hormone changes — a concept now widely accepted and informing both surgical and pharmaceutical approaches to obesity.

The bigger picture

This study bridges bariatric surgery and the peptide hormone revolution. The finding that sleeve gastrectomy naturally boosts GLP-1 and reduces ghrelin mirrors what GLP-1 agonist drugs like semaglutide do pharmacologically — suggesting that successful obesity treatments, whether surgical or pharmaceutical, converge on the same gut peptide signaling pathways.

Questions still open

  • Do the GLP-1 and ghrelin changes persist years after sleeve gastrectomy, or do they attenuate over time?
  • Could combining sleeve gastrectomy with GLP-1 agonist drugs provide additive weight loss benefits?
  • Is the CCK response after surgery related to the accelerated gastric emptying, and which is more important for satiety?

Common questions

Why does sleeve gastrectomy affect gut hormones if it's just removing part of the stomach?
The portion of stomach removed during sleeve gastrectomy is rich in cells that produce ghrelin (the hunger hormone). Removing this tissue dramatically reduces ghrelin production. Additionally, the altered stomach shape causes food to reach the intestines faster, triggering earlier and stronger release of satiety hormones like GLP-1 and cholecystokinin.
Is sleeve gastrectomy doing the same thing as GLP-1 drugs like Ozempic?
In some ways, yes. Both increase GLP-1 signaling, reduce appetite, and improve insulin sensitivity. Sleeve gastrectomy does this by physically changing the stomach and boosting the body's own GLP-1 production, while drugs like semaglutide deliver a synthetic version of GLP-1 directly. Both approaches converge on the same hormonal pathways.

Read the original research

Sleeve gastrectomy effects on hunger, satiation, and gastrointestinal hormone and motility responses after a liquid meal test.

The American journal of clinical nutrition, 102(3), 540-7

Citation

Mans, Esther; Serra-Prat, Mateu; Palomera, Elisabet; Suñol, Xavier; Clavé, Pere. (2015). Sleeve gastrectomy effects on hunger, satiation, and gastrointestinal hormone and motility responses after a liquid meal test.. The American journal of clinical nutrition, 102(3), 540-7. https://doi.org/10.3945/ajcn.114.104307